Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page updates primarily refresh date-related content (new dates added, old dates removed) and IPD planning labels, with no major changes to core content or pricing.
    Difference
    2%
    Check dated 2025-10-20T15:20:54.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a government-operating-status notice and a removal of the previous v3.1.0 marker.
    Difference
    4%
    Check dated 2025-10-06T06:38:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:14:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.1 to Revision: v3.0.2; removed the Back to Top element, signaling a new release with a small UI cleanup.
    Difference
    0.2%
    Check dated 2025-09-14T20:02:22.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T17:00:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility and location information, as well as a range of medical topics related to cancer and immunology. Notably, several previous topics and terms related to lung cancer and certain antineoplastic agents have been removed.
    Difference
    5%
    Check dated 2025-08-31T12:13:27.000Z thumbnail image

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.